Showing results (221-230 of 229) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 229 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancerJanos L Tanyi, Yutaka Hasegawa, Ruth Lapushin, et al.
Plos One|January 7, 2015
Implications of the circumpolar genetic structure of polar bears for their conservation in a rapidly warming ArcticElizabeth Peacock, Sarah A Sonsthagen, Martyn E Obbard, et al.
The Medical Journal of Australia|February 20, 2013
Respiratory symptoms and illness in older Australians: the Burden of Obstructive Lung Disease (BOLD) studyBrett G Toelle, Wei Xuan, Tessa E Bird, et al.
Journal of Medicinal Chemistry|May 10, 2022
Design of a Potent, Selective, and Brain-Penetrant Inhibitor of Wnt-Deactivating Enzyme Notum by Optimization of a Crystallographic Fragment HitNicky J Willis, William Mahy, James Sipthorp, et al.
Bioorganic & Medicinal Chemistry|October 23, 2010
Discovery and biological evaluation of potent, selective, orally bioavailable, pyrazine-based blockers of the Na(v)1.8 sodium channel with efficacy in a model of neuropathic painMarc J C Scanio, Lei Shi, Irene Drizin, et al.
Cell Host & Microbe|September 17, 2025
Gut microbiota and metabolites drive chronic sickle cell disease pain in miceAmanda M Brandow, Samantha N Atkinson, Zulmary Manjarres, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2010
Subtype-selective Na(v)1.8 sodium channel blockers: identification of potent, orally active nicotinamide derivativesMichael E Kort, Robert N Atkinson, James B Thomas, et al.
Bioorganic & Medicinal Chemistry|May 27, 2008
Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic painIrene Drizin, Robert J Gregg, Marc J C Scanio, et al.
Journal of Medicinal Chemistry|January 8, 2008
Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory painMichael E Kort, Irene Drizin, Robert J Gregg, et al.
Pageof 23